Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Invokana (canagliflozin) and Afrezza (insulin human) are both medications used to manage diabetes, but they work in different ways. Invokana is a sodium-glucose cotransporter 2 (SGLT2) inhibitor taken orally once a day to help lower blood sugar in adults with Type 2 diabetes. It also reduces the risk of heart and kidney problems in these individuals. Afrezza, on the other hand, is an ultra rapid-acting insulin inhaled at the start of meals, used for both Type 1 and Type 2 diabetes. Invokana and Afrezza are only available as brand-name medications. Invokana can cause side effects like urinary tract infections and yeast infections, while Afrezza may lead to low blood sugar and cough, and is not suitable for people with lung issues like asthma. Both medications can be used with other diabetes medications, but blood sugar monitoring is recommended because of the increased risk of low blood sugar.
Invokana (canagliflozin)
Afrezza (insulin)
Invokana (canagliflozin)
Afrezza (insulin)
Summary of Invokana vs. Afrezza
Summary for SGLT2 inhibitor
Prescription only
Invokana (canagliflozin) is a medication that's used together with a healthy diet and exercise to lower blood sugar levels in adults with Type 2 diabetes. It can also lessen the chance of worsening heart and kidney problems in some people with Type 2 diabetes. This medication is taken by mouth once a day.
Summary for Insulin
Prescription only
Afrezza is an ultra rapid-acting inhaled insulin for adults with diabetes. It helps manage blood sugar levels from meals. You breathe in the medication through the mouth using the Afrezza inhaler usually at the start of meals. Common side effects are low blood sugar and cough. There's also a risk of bronchospasm (sudden narrowing of the airways), which can make it hard to breathe. So Afrezza (insulin) isn't for people with breathing problems like asthma or chronic obstructive pulmonary disease (COPD).
Indications of Invokana vs. Afrezza
Indications for
•Type 2 diabetes
•Lowering the risk of major heart events (e.g., heart attack, stroke) in adults with Type 2 diabetes and heart disease
•Lowering the risk of hospitalization for heart failure, death due to heart problems, and worsening of kidney problems in certain adults with Type 2 diabetes and diabetic kidney disease